Zomedica Corp. (ZOM)
AMEX: ZOM
· Real-Time Price · USD
0.10
0.00 (2.56%)
At close: Mar 04, 2025, 9:50 AM
2.56% (1D)
Bid | 0.1 |
Market Cap | 95.35M |
Revenue (ttm) | 26.73M |
Net Income (ttm) | -62.19M |
EPS (ttm) | -0.06 |
PE Ratio (ttm) | -1.6216666666666666 |
Forward PE | n/a |
Analyst | n/a |
Ask | 0.1 |
Volume | 790,936 |
Avg. Volume (20D) | 8,541,418 |
Open | 0.09 |
Previous Close | 0.10 |
Day's Range | 0.09 - 0.10 |
52-Week Range | 0.02 - 0.20 |
Beta | 1.16 |
Next Earnings Release
Zomedica Corp. is scheduled to release its earnings on May 8, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 year ago
Shares of pet-related stocks are trading higher af...
Unlock content with
Pro Subscription
1 year ago
Zomedica shares are trading higher after the company announced the launch of Over-the-Air software and firmware update capability for its TRUFORMA point-of-care diagnostic platform.

4 months ago · businesswire.com
NYSE American to Commence Delisting Proceedings Against Zomedica Corp. (ZOM)NEW YORK--(BUSINESS WIRE)--NYSE American LLC (“NYSE American” or the “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the common shares of...

4 months ago · accessnewswire.com
Zomedica Improves Efficiency and Cuts Costs by Moving to New HeadquartersRelocation to More Efficient Space Supports Growth While Reducing Overhead by Over $200,000 Annually ANN ARBOR, MI / ACCESS Newswire / February 12, 2025 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica...

4 months ago · accessnewswire.com
Zomedica Launches the TRUFORMA(R) Enhanced Endogenous ACTH Assay to aid in Equine PPID DiagnosisZomedica continues to redefine what is possible in point of care diagnostics with the TRUFORMA biosensor platform ANN ARBOR, MI / ACCESS Newswire / February 6, 2025 / Zomedica Corp. (NYSE American:ZOM...